ProQR Therapeutics
PRQR • NASDAQ
ProQR Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel Anton de Boer, with a market cap of $182.8M.
Market Cap$182.8M
Employees157.0
CEODaniel Anton de Boer
CountryNetherlands
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
ProQR Therapeutics FAQ
Common questions about ProQR Therapeutics
ProQR Therapeutics is scheduled to report earnings for Q1 2026 on May 14, 2026 before market open. Analysts estimate revenue of $5.1M.
ProQR Therapeutics has approximately 157 employees.